Home> Products> dual action diabetes management medications

{ "products": [ { "_id": "6891f29bfb7044dfb2d43adf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MAGRAL 160", "description": "MAGRAL 160 is a pharmaceutical medication containing megestrol acetate 160 mg, a synthetic progestin known for its potent antineoplastic and appetite-stimulating properties. This drug is primarily prescribed to manage significant health challenges such as unexplained weight loss, anorexia, and cachexia, especially in patients suffering from chronic conditions like cancer or AIDS. Additionally, megestrol acetate functions as a hormone therapy agent employed in the treatment of certain hormone-sensitive malignancies. Its dual action both supports tumor management and improves patients' nutritional status by stimulating appetite and promoting weight gain, thereby enhancing overall quality of life. The drug is regarded as a crucial option in oncology and palliative care for managing complex conditions related to hormone-dependent cancers and severe wasting syndromes.\n\nWhat is MAGRAL 160?\nMAGRAL 160 is an oral medication formulated with megestrol acetate 160 mg, a synthetic progestin hormone derivative. It works primarily by modulating hormone receptors and altering hormone levels that influence the growth of hormone-responsive tumors such as breast and endometrial cancers. Apart from its antineoplastic action, it stimulates appetite by acting on the hypothalamic centers responsible for hunger, helping patients suffering from severe weight loss regain a healthy appetite and weight.\n\nUses of MAGRAL 160\n\nTo treat hormone-dependent cancers, specifically advanced breast cancer and endometrial cancer.\n\nTo stimulate appetite and promote weight gain in patients experiencing anorexia, cachexia, or unexplained severe weight loss related to chronic illnesses like cancer or AIDS.\n\nTo manage wasting syndromes that lead to malnutrition and significant weight loss.\n\nTo serve as an antineoplastic agent in hormone-sensitive malignancies.\n\nIn short, MAGRAL 160 is primarily used to treat anorexia and cachexia or serious unexplained weight loss and is also used as an antineoplastic agent to treat certain types of malignancy.\n\nSide Effects of MAGRAL 160\n\nWeight gain (often desirable but can be excessive)\n\nFluid retention and edema (swelling)\n\nNausea and vomiting\n\nDiarrhea or constipation\n\nVaginal bleeding or spotting in women\n\nFatigue, weakness, and insomnia\n\nHeadache and dizziness\n\nIncreased risk of blood clots (deep vein thrombosis or pulmonary embolism)\n\nHormonal imbalances, such as decreased sex hormone levels, which can lead to sexual dysfunction or bone density loss\n\nAllergic reactions including rash or itching\n\nPatients should report severe or unusual symptoms, especially signs of blood clots such as limb swelling, chest pain, or sudden shortness of breath, immediately to their healthcare provider.\n\nPrecautions before Using MAGRAL 160\n\nInform your doctor if you are pregnant, breastfeeding, or planning to conceive as MAGRAL 160 is contraindicated in pregnancy.\n\nDisclose any history of blood clots, cardiovascular diseases, liver or kidney impairment.\n\nPatients with diabetes should monitor blood sugar closely as megestrol acetate may cause hyperglycemia.\n\nAvoid sudden discontinuation without medical advice to prevent potential hormonal withdrawal effects.\n\nRegular monitoring is required, including hormone levels and blood tests, to assess efficacy and safety during treatment.\n\nUse cautiously in patients at risk for deep vein thrombosis or pulmonary embolism due to increased clotting risks.\n\nDrug Interactions: What Drugs Interact with MAGRAL 160?\n\nCYP3A4 enzyme inducers (e.g., rifampin, phenytoin) may reduce the effectiveness of megestrol acetate by increasing its metabolism.\n\nConcurrent use with blood thinners (anticoagulants) requires careful monitoring as MAGRAL 160 might influence clotting parameters.\n\nCombining with drugs that affect hormonal pathways, such as other hormonal therapies or corticosteroids, may alter treatment outcomes.\n\nInteractions with diabetes medications might necessitate dose adjustment due to potential effects on blood sugar control.\n\nCareful medical supervision is necessary when used with immunosuppressants or other chemotherapy agents to avoid additive side effects or altered drug levels.\n\nConclusion\nMAGRAL 160, containing megestrol acetate 160 mg, is a clinically validated medication widely used to manage complex conditions such as hormone-dependent cancers as well as severe weight loss due to anorexia and cachexia. Its unique ability to act both as an antineoplastic agent and an appetite stimulant makes it invaluable in improving patient outcomes, nutritional status, and overall quality of life. Patients prescribed MAGRAL 160 should adhere strictly to their healthcare provider’s instructions and report any adverse effects promptly. This medication should always be used under medical supervision to ensure optimal benefits and minimize risks.", "price": 810.0, "discountamount": 243.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2156, "imageuri": "https://productimages.withfloats.com/actual/6891f2a0115b51057b971998.png", "tileimageuri": "https://productimages.withfloats.com/tile/6891f2a0115b51057b971998.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-05T12:01:31.195Z", "updatedon": "2025-08-05T12:01:31.195Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//magral-160/2156", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "megestrol acetate 160 mg", "category": "Gynaecology", "tags": [ "megestrol acetate 160 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6890aa548a215c65672372e1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "EMPATECH LINA 25/5", "description": "EMPATECH LINA 25/5 is a pharmaceutical tablet containing a combination of two active ingredients: Empagliflozin 25MG and Linagliptin 5MG. This medication is designed to help manage blood sugar levels in adults with type 2 diabetes mellitus. The combination works through complementary mechanisms to improve glycemic control more effectively than either drug alone. Empagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor that promotes the excretion of excess glucose through urine, while Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and suppresses glucagon release, particularly after meals. EMPATECH LINA 25/5 is generally prescribed alongside a balanced diet and regular exercise to optimize blood sugar management and reduce the risk of diabetes-related complications such as kidney damage, neuropathy, and cardiovascular issues.\n\nWhat is EMPATECH LINA 25/5?\n\nEMPATECH LINA 25/5 is a prescription medication combining Empagliflozin (25MG) and Linagliptin (5MG) tablets used to manage type 2 diabetes. It helps control elevated blood sugar levels by using dual actions — the removal of glucose via kidneys and improving pancreatic hormone responses. This combination aims to achieve better and sustained glycemic control, often necessary for patients who have inadequate blood sugar control with other treatments.\n\nUses of EMPATECH LINA 25/5\n\nTo improve blood sugar control in adults with type 2 diabetes, particularly when monotherapy is insufficient.\n\nOften used as a second-line therapy after metformin or when metformin is not tolerated.\n\nTo reduce HbA1c (hemoglobin A1c), an important measure of long-term glucose control.\n\nMay help reduce weight and blood pressure as empagliflozin aids in glucose excretion.\n\nSupports comprehensive diabetes management along with diet and exercise.\n\nPrevents or reduces the risk of diabetes-associated complications such as kidney disease, cardiovascular events, and nerve damage.\n\nSide Effects of EMPATECH LINA 25/5\n\nCommon side effects may include urinary tract infections and genital infections due to increased glucose in urine.\n\nIncreased urination and dehydration.\n\nDizziness or lightheadedness, especially when standing up quickly.\n\nHypoglycemia (low blood sugar), though rare with this combination.\n\nGastrointestinal symptoms such as nausea or diarrhea.\n\nPotential increased risk of ketoacidosis (a serious condition related to high blood acids) in rare cases.\n\nAllergic reactions, although uncommon, may occur and require prompt medical attention.\n\nPrecautions Before Using EMPATECH LINA 25/5\n\nInform your healthcare provider if you have kidney disease, liver problems, or a history of urinary tract infections.\n\nNot recommended for type 1 diabetes or diabetic ketoacidosis treatment.\n\nUse with caution if you are pregnant, planning to become pregnant, or breastfeeding.\n\nStay hydrated while on this medication to reduce the risk of dehydration and dizziness.\n\nInform your doctor about any history of pancreatitis or pancreas disorders.\n\nRegular monitoring of kidney function and blood sugar levels is advised during treatment.\n\nAvoid drinking excessive alcohol as it may increase side effects or risk of ketoacidosis.\n\nDrug Interactions: What Drugs Interact with EMPATECH LINA 25/5?\n\nOther antidiabetic medications, such as insulin or sulfonylureas, may increase the risk of hypoglycemia.\n\nDiuretics, blood pressure medications, and lithium may interact and increase side effects.\n\nDrugs that impair kidney function can affect empagliflozin’s efficacy and safety.\n\nCertain enzyme-inducing drugs may reduce linagliptin levels, lowering its effectiveness.\n\nConsult your healthcare provider for a full list of possible interactions and before starting any new medication, including over-the-counter drugs or supplements.\n\nConclusion\n\nEMPATECH LINA 25/5, containing Empagliflozin 25MG and Linagliptin 5MG, is an effective combination medication to treat high blood sugar levels caused by type 2 diabetes. Its dual-action approach targets different physiological mechanisms to improve blood glucose control, helping reduce the risks and complications associated with diabetes. While it is generally well-tolerated, awareness of possible side effects and drug interactions is important. Always use under medical supervision, alongside lifestyle modifications such as diet and exercise, for optimal diabetes management.", "price": 345.0, "discountamount": 104.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2154, "imageuri": "https://productimages.withfloats.com/actual/6890aa58dd0bc098c3220f4c.png", "tileimageuri": "https://productimages.withfloats.com/tile/6890aa58dd0bc098c3220f4c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-04T12:40:52.619Z", "updatedon": "2025-08-04T12:40:52.619Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empatech-lina-25-5/2154", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin and Linagliptin Tablets", "category": "DIABETIC RANGE", "tags": [ "Empagliflozin and Linagliptin Tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6825c6cc966e2a18bb4b35a6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPA PIO", "description": "GLIDAPA PIO is a combination oral medication specially formulated to help manage type 2 diabetes mellitus. It combines two powerful antidiabetic agents, dapagliflozin and pioglitazone, to effectively control blood sugar levels. This medication is prescribed to patients when diet and exercise alone do not provide adequate glycemic control. By addressing blood glucose regulation through different mechanisms, GLIDAPA PIO helps reduce the risk of diabetes-related complications and supports overall metabolic health.\n\nKey Ingredients\nDapagliflozin (10mg): A sodium-glucose co-transporter 2 (SGLT2) inhibitor that helps lower blood sugar by increasing the excretion of glucose through urine.\n\nPioglitazone (15mg): A thiazolidinedione that improves insulin sensitivity by acting on fat, muscle, and liver cells, facilitating better glucose uptake and utilization.\n\nKey Benefits\nHelps maintain stable blood glucose levels in adults with type 2 diabetes.\n\nCombines two complementary mechanisms to enhance blood sugar control.\n\nSupports weight management due to dapagliflozin’s glucose excretion effect.\n\nMay improve insulin sensitivity and reduce insulin resistance.\n\nReduces the risk of diabetes-related complications such as cardiovascular problems when combined with lifestyle changes.\n\nConvenient once-daily tablet formulation.\n\nHow Does It Work?\nDapagliflozin blocks SGLT2 proteins in the kidneys, preventing glucose reabsorption and promoting its elimination through urine, which lowers blood glucose. Pioglitazone acts on insulin-responsive tissues, enhancing the body’s sensitivity to insulin. This dual action helps reduce both insulin resistance and excess blood glucose, providing better overall glycemic control. By targeting different pathways, GLIDAPA PIO offers a synergistic effect to manage type 2 diabetes more effectively.\n\nDirections for Use\nTake GLIDAPA PIO exactly as prescribed by your healthcare provider.\n\nUsually taken once daily, with or without food, at the same time each day.\n\nDo not skip doses or stop the medication without consulting your doctor.\n\nMaintain a balanced diet and regular exercise as advised alongside the medication.\n\nInform your doctor about any other medications you are taking to avoid potential interactions.\n\nSide Effects\nSome patients may experience side effects while taking GLIDAPA PIO, including:\n\nUrinary tract infections or increased urination due to dapagliflozin.\n\nWeight gain or swelling caused by pioglitazone.\n\nRisk of low blood sugar (hypoglycemia) when combined with other antidiabetic drugs.\n\nPossible dizziness or fatigue.\n\nRarely, heart failure or bladder cancer risk (associated with pioglitazone).\n\nIf you notice symptoms like excessive thirst, sudden weight gain, swelling, shortness of breath, or any allergic reactions, seek medical advice immediately.", "price": 255.0, "discountamount": 77.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "medication inform", "pioglitazone risk", "regular exercise", "balanced diet", "doctor maintain", "glucose uptake", "notice symptoms", "antidiabetic drugs", "swelling caused", "advised alongside", "skip doses", "healthcare provider", "effectively directions", "synergistic effect", "glycemic control", "cardiovascular problems", "complementary mechanisms", "fat muscle", "diabetesrelated complications", "insulin resistance", "bodys sensitivity", "glidapa pio", "urine pioglitazone 15mg", "taking glidapa pio", "bladder cancer risk", "improve insulin sensitivity", "improves insulin sensitivity", "glidapa pioglidapa pio", "dapagliflozin weight gain", "increased urination due", "urinary tract infections", "experience side effects", "insulinresponsive tissues enhancing", "liver cells facilitating" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2114, "imageuri": "https://productimages.withfloats.com/actual/6825c6ce65488af627fb2e46.png", "tileimageuri": "https://productimages.withfloats.com/tile/6825c6ce65488af627fb2e46.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-15T10:49:48.361Z", "updatedon": "2025-05-15T10:50:30.602Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapa-pio/2114", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Dapagliflozin 10mg and pioglitazone 15mg tablets", "category": "DIABETIC RANGE", "tags": [ "Dapagliflozin, pioglitazone combination", "Dapagliflozin, pioglitazone combination", "Dapagliflozin Pioglitazone CDSCO" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67e152b7204f0ac1d74d3bb7", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin 10 mg, Sitagliptin 100 mg", "description": "GLIEMPAFLOZIN SITA 10/100 is a powerful combination of Empagliflozin 10 mg and Sitagliptin 100 mg designed to effectively manage Type 2 Diabetes Mellitus. This dual-action formula helps regulate blood sugar levels, improves insulin sensitivity, and supports overall metabolic health. It is ideal for individuals who require an advanced approach to diabetes management while reducing the risk of complications.\n\n \nKey Benefits:\n \n\nEffective Blood Sugar Control – Helps maintain stable glucose levels throughout the day.\nDual-Action Formula – Targets blood sugar from different pathways for enhanced efficacy.\nWeight Management Support – Aids in mild weight loss by reducing excess glucose.\nCardiovascular Protection – May lower the risk of heart-related complications.\nReduces Risk of Hypoglycemia – Less likelihood of sudden blood sugar drops compared to some other diabetes medications.\n\n \nHow Does It Work?\n \n\nEmpagliflozin works by preventing glucose reabsorption in the kidneys, allowing excess sugar to be eliminated through urine.\n\nSitagliptin increases insulin production while reducing the liver’s glucose output, leading to improved blood sugar control.\n\nTogether, these ingredients offer a comprehensive diabetes treatment approach, making it easier to maintain healthy glucose levels.\n\nDirections for Use:\n \n\nTake GLIEMPAFLOZIN SITA 10/100 as prescribed by your doctor.\n\nSwallow the tablet whole with a glass of water.\n\nCan be taken with or without food.\n\nMaintain a balanced diet and regular exercise for best results.\n\nDo not exceed the recommended dosage.\n\n \nSide Effects:\n \n\nWhile generally well-tolerated, some individuals may experience:\n\nIncreased Urination\nMild Nausea or Stomach Discomfort\nHeadache or Dizziness\nUrinary Tract Infections (UTIs)\nLow Blood Pressure (in some cases)\n\nSeek medical attention if you experience severe allergic reactions, dehydration, or persistent discomfort.", "price": 365.0, "discountamount": 110.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "generally welltolerated", "regular exercise", "balanced diet", "food maintain", "doctor swallow", "gliempaflozin sita 10100", "ingredients offer", "diabetes medications", "diabetes management", "advanced approach", "metabolic health", "powerful combination", "persistent discomfort", "empagliflozin 10mg", "stomach discomfort headache", "work empagliflozin works", "preventing glucose reabsorption", "mild weight loss", "sitagliptin 100mg designed" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2072, "imageuri": "https://productimages.withfloats.com/actual/67e152c98868d014155bafa6.png", "tileimageuri": "https://productimages.withfloats.com/tile/67e152c98868d014155bafa6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-03-24T12:40:23.819Z", "updatedon": "2025-03-27T12:58:36.708Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-10-mg-sitagliptin-100-mg/2072", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN SITA 10/100", "category": "DIABETIC RANGE", "tags": [ "Empagliflozin and sitagliptin combination", "Empagliflozin and sitagliptin tablets", "Empagliflozin and sitagliptin combination brands", "Empagliflozin and sitagliptin tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67c5887fcd301704c9b6528a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Repaglinide 0.5mg", "description": "RAPIGLINIDE 0.5 contains Repaglinide 0.5 mg, a medication used in the treatment of Type 2 diabetes mellitus. It belongs to a class of drugs known as meglitinides, which help control blood sugar levels by stimulating insulin production from the pancreas. RAPIGLINIDE is commonly prescribed to individuals who are unable to maintain optimal blood glucose levels through diet and exercise alone. It can be used alone or in combination with other oral diabetes medications to help manage blood sugar levels effectively.\n\n \nKey Benefits:\n \n Effective Blood Sugar Control – Helps lower postprandial blood glucose levels, effectively managing blood sugar spikes after meals.\n Rapid Action – Starts working quickly, offering fast relief from elevated blood sugar levels.\n Flexible Dosing – Can be taken before meals, giving flexibility in meal planning and diabetes management.\n Helps Prevent Complications of Diabetes – By controlling blood sugar levels, it helps in reducing the risk of complications associated with diabetes, such as nerve damage, heart disease, and kidney issues.\n Used Alone or with Other Diabetes Medications – RAPIGLINIDE 0.5 can be combined with other oral diabetes drugs for better blood sugar management.\n\n \nHow Does It Work?\n \n\nRepaglinide 0.5 mg works by stimulating the beta cells in the pancreas to secrete insulin when blood sugar levels rise after meals. The medication acts quickly, allowing the body to use glucose more effectively and preventing high blood sugar spikes. Unlike other long-acting insulin medications, Repaglinide acts quickly but for a short duration, making it suitable for controlling blood sugar right after eating. It helps in maintaining optimal postprandial glucose levels, which is crucial for the management of Type 2 diabetes.\n\n \nDirections for Use:\n \n\nTake RAPIGLINIDE 0.5 exactly as prescribed by your doctor.\nThe typical dosage is 0.5 mg to 2 mg taken before meals, 2 to 3 times daily.\nSwallow the tablet whole with water.\nDo not take more than the prescribed dose, and never skip doses.\nIf you miss a dose, take it as soon as you remember before the next meal. If it's almost time for your next meal, skip the missed dose—do not double the dose.\n \nSide Effects:\n \n\nWhile RAPIGLINIDE 0.5 is generally well-tolerated, some people may experience:\n\nHypoglycemia (low blood sugar): Symptoms include dizziness, sweating, shaking, confusion, and headaches.\nNausea or diarrhea\nWeight gain (in some cases)\nHeadache or dizziness\nRash or itching (rare)\nAbdominal discomfort\nIf you experience any signs of severe hypoglycemia (such as confusion, blurred vision, or seizures), or severe allergic reactions (such as difficulty breathing, swelling of the face or throat), seek immediate medical attention.", "price": 217.0, "discountamount": 66.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "2 mg", "05 mg", "rapiglinide 05", "meals 2", "pancreas rapiglinide", "repaglinide 05 mg", "meal skip", "prescribed dose", "meal planning", "commonly prescribed", "medical attention", "throat seek", "dizziness rash", "cases headache", "headaches nausea", "generally welltolerated", "missed dosedo", "skip doses", "typical dosage", "beta cells", "kidney issues", "repaglinide 05mgrapiglinide 05", "severe hypoglycemia", "secrete insulin", "oral diabetes drugs", "stimulating insulin production", "meals giving flexibility", "dose side effects", "blood sugar management", "oral diabetes medications", "severe allergic reactions", "difficulty breathing swelling", "confusion blurred vision", "diarrhea weight gain", "controlling blood sugar", "short duration making" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2063, "imageuri": "https://productimages.withfloats.com/actual/67c588a2587befa5fb853a41.png", "tileimageuri": "https://productimages.withfloats.com/tile/67c588a2587befa5fb853a41.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-03-03T10:46:23.834Z", "updatedon": "2025-03-03T10:46:56.222Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/repaglinide-0-5mg/2063", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "RAPIGLINIDE 0.5", "category": "DIABETIC RANGE", "tags": [ "Repaglinide 0.5 Mg Tablet Uses in Hindi", "Repaglinide 0.5 mg tablet uses", "Repaglinide 0.5 mg brand name", "Repaglinide brand name", "Repaglinide side effects 0.5 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67a35e1c4d6823e26538d21d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin (12.5mg), Metformin Hydrochloride (500mg)", "description": "GLIEMPAFLOZIN MET 12.5mg/500mg is a powerful combination medication formulated to manage type 2 diabetes mellitus (T2DM) effectively. It contains Empagliflozin (12.5mg) and Metformin Hydrochloride (500mg), two potent anti-diabetic agents that work synergistically to regulate blood sugar levels. This medication helps in improving glycemic control while reducing the risk of diabetes-related complications. It is prescribed as an adjunct to diet and exercise to enhance blood glucose regulation in adults with type 2 diabetes.\n\n \nKey Benefits:\n \n\n Effective Blood Sugar Control: Helps in lowering HbA1c levels, leading to better long-term glucose management.\nPromotes Weight Loss: Empagliflozin assists in weight reduction by eliminating excess glucose through urination.\nReduces Cardiovascular Risk: Beneficial for patients with heart-related complications linked to diabetes.\nImproves Insulin Sensitivity: Metformin enhances insulin action, reducing insulin resistance.\nPrevents Kidney Damage: Helps in reducing the burden on kidneys by decreasing glucose reabsorption.\nConvenient Combination Therapy: Eliminates the need for multiple medications by combining two effective drugs in one tablet.\n \nHow Does It Work?\n \n\nGLIEMPAFLOZIN MET 12.5mg/500mg works through a dual mechanism:\n\nEmpagliflozin blocks SGLT2 in the kidneys, preventing glucose reabsorption and promoting its excretion through urine. This leads to a significant reduction in blood sugar levels.\n\nMetformin lowers hepatic glucose production, decreases intestinal glucose absorption, and enhances insulin sensitivity, ensuring better blood glucose utilization by the body.\n\n \nDirections for Use:\n \n\nTake one tablet daily or as directed by your healthcare provider.\n\nSwallow the tablet whole with a glass of water. Do not crush or chew it.\n\nIt is recommended to take the medication with food to minimize gastrointestinal side effects.\n\nFollow a balanced diet and regular exercise regimen for optimal results.\n\nMonitor blood sugar levels regularly to ensure proper dosage adjustments.\n\n \nSide Effects:\n \n\nAlthough GLIEMPAFLOZIN MET 12.5mg/500mg is well tolerated, some patients may experience mild to moderate side effects, including:\n\nFrequent Urination due to glucose excretion\n\nDehydration or thirst\n\nHypoglycemia (Low Blood Sugar) when used with other anti-diabetic medications\n\nGastrointestinal Issues such as nausea, diarrhea, or stomach discomfort\n\nUrinary Tract Infections (UTIs) due to increased glucose in urine\n\nLactic Acidosis (Rare but Serious) in some cases due to Metformin", "price": 155.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "tablet daily", "balanced diet", "medication helps", "nausea diarrhea", "experience mild", "body directions", "significant reduction", "effective drugs", "multiple medications", "weight reduction", "work synergistically", "empagliflozin 125mg", "cases due", "diabetesrelated complications", "increased glucose", "glucose excretion dehydration", "regular exercise regimen", "metformin hydrochloride 500mg", "frequent urination due", "heartrelated complications linked", "blood glucose utilization", "eliminating excess glucose", "moderate side effects", "gliempaflozin met 125mg500mg", "healthcare provider swallow", "improving glycemic control", "potent antidiabetic agents" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2050, "imageuri": "https://productimages.withfloats.com/actual/67a35e57b167fbeb7927d316.png", "tileimageuri": "https://productimages.withfloats.com/tile/67a35e57b167fbeb7927d316.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-05T12:48:28.684Z", "updatedon": "2025-03-17T11:04:23.276Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-12-5mg-metformin-hydrochloride-500mg-/2050", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN MET 12.5mg/ 500mg", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 12.5 mg+metformin 500 mg", "empagliflozin/metformin 5 mg/1000 mg", "Empagliflozin 12.5 mg brands in India", "empagliflozin 12.5 mg+metformin 500 mg price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67a359d62a16e824ce228063", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin (5mg) , Metformin Hydrochloride (1000mg)", "description": "GLIEMPAFLOZIN MET 5mg/1000mg is a combination medication formulated to manage type 2 diabetes mellitus (T2DM) effectively. It contains Empagliflozin (5mg) and Metformin Hydrochloride (1000mg), two powerful antidiabetic agents that work together to regulate blood sugar levels. This medication helps improve glycemic control, reduce insulin resistance, and lower the risk of diabetes-related complications when combined with a healthy diet and regular exercise.\n\n \n\nKey Benefits:\n \n\nEffective Blood Sugar Control – Regulates blood glucose levels by decreasing sugar production and enhancing excretion.\n\nWeight Management – Empagliflozin helps in weight reduction by promoting calorie loss through urinary glucose excretion.\n\nReduced Cardiovascular Risks – Lowers the risk of heart disease in diabetic patients.\n\nImproved Insulin Sensitivity – Enhances the body's response to insulin and reduces insulin resistance.\n\nSupports Kidney Function – Helps prevent diabetes-related kidney complications.\n\nLowers the Risk of Hypoglycemia – Unlike some other diabetes medications, it reduces the chances of sudden blood sugar drops.\n\n \nHow Does It Work?\n \n\nGLIEMPAFLOZIN MET 5mg/1000mg combines two distinct yet complementary mechanisms of action:\n\nEmpagliflozin (SGLT2 Inhibitor) – Blocks glucose reabsorption in the kidneys, causing excess sugar to be eliminated through urine, thereby lowering blood sugar levels.\n\nMetformin (Biguanide) – Works by decreasing hepatic glucose production, increasing insulin sensitivity, and reducing intestinal glucose absorption. This results in overall better glycemic control.\n\n \nDirections for Use:\n \n\nTake GLIEMPAFLOZIN MET 5mg/1000mg once or twice daily as directed by your healthcare provider.\n\nSwallow the tablet whole with water; do not crush or chew.\n\nIt is best taken with meals to minimize gastrointestinal side effects.\n\nFollow a balanced diet and engage in regular physical activity for optimal diabetes management.\n\nDo not skip doses or stop medication without consulting a doctor.\n\n \nSide Effects:\n \n\nAlthough GLIEMPAFLOZIN MET 5mg/1000mg is well-tolerated, some individuals may experience side effects such as:\n\nFrequent urination (due to glucose excretion)\n\nDehydration and electrolyte imbalances\n\nGastrointestinal issues – Nausea, vomiting, diarrhea, or stomach discomfort\n\nUrinary tract infections (UTIs)\n\nGenital infections (yeast infections)\n\nLactic acidosis (rare but serious) due to metformin accumulation\n\nLow blood pressure (hypotension)", "price": 125.0, "discountamount": 38.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "skip doses", "balanced diet", "complementary mechanisms", "hypoglycemia unlike", "bodys response", "heart disease", "weight reduction", "healthy diet", "diabetesrelated complications", "empagliflozin 5mg", "stop medication", "diabetes medications", "frequent urination due", "optimal diabetes management", "combination medication formulated", "glucose excretion dehydration", "experience side effects", "doctor side effects", "regular physical activity", "healthcare provider swallow", "gliempaflozin met 5mg1000mg", "glycemic control directions", "promoting calorie loss", "decreasing sugar production", "powerful antidiabetic agents", "metformin hydrochloride 1000mg" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2046, "imageuri": "https://productimages.withfloats.com/actual/67a359edd87a03335028ee95.png", "tileimageuri": "https://productimages.withfloats.com/tile/67a359edd87a03335028ee95.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-05T12:30:14.031Z", "updatedon": "2025-03-27T09:44:28.311Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-5mg-metformin-hydrochloride-1000mg-/2046", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN MET 5mg/ 1000mg ", "category": "DIABETIC RANGE", "tags": [ "empagliflozin/metformin 5 mg/1000 mg", "empagliflozin/metformin 5 mg/500 mg", "empagliflozin + metformin combination brand name", "empagliflozin + metformin brand name in india", "Empagliflozin and metformin hydrochloride tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67a35767912e6c5ba00a1473", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin (5mg) ,Metformin Hydrochloride (500mg)", "description": "GLIEMPAFLOZIN MET is an advanced oral medication designed for the effective management of Type 2 Diabetes Mellitus. This combination of Empagliflozin (5mg) and Metformin Hydrochloride (500mg) helps regulate blood sugar levels, improve insulin sensitivity, and reduce the risk of diabetes-related complications. It is commonly prescribed as part of a comprehensive diabetes care plan, including diet and lifestyle modifications.\n\n \nKey Benefits:\n \n\nEffective Blood Sugar Control – Helps maintain stable blood glucose levels.\nReduces Insulin Resistance – Enhances the body's ability to utilize insulin efficiently.\nPromotes Weight Management – Empagliflozin aids in weight loss by eliminating excess glucose.\nImproves Cardiovascular Health – Lowers the risk of heart disease in diabetic patients.\nSupports Kidney Function – Helps reduce the progression of diabetic kidney disease.\nLower Risk of Hypoglycemia – Unlike some other diabetes medications, it has a lower risk of causing dangerously low blood sugar levels.\n \nHow Does It Work?\n \n\nGLIEMPAFLOZIN MET combines two powerful antidiabetic agents to provide synergistic effects:\n\nEmpagliflozin (SGLT2 Inhibitor): Blocks glucose reabsorption in the kidneys, allowing excess sugar to be excreted through urine. This helps lower blood glucose levels effectively.\nMetformin (Biguanide): Works by decreasing glucose production in the liver and improving insulin sensitivity, leading to better glucose utilization by body tissues.\nTogether, these mechanisms help in long-term diabetes management, reducing complications and improving overall well-being.\n\n \nDirections for Use:\n \n\nTake one tablet as prescribed by your healthcare provider.\nPreferably consume with meals to minimize stomach discomfort.\nSwallow the tablet whole with water; do not crush or chew.\nMaintain a healthy diet and exercise routine for optimal results.\nRegular blood sugar monitoring is recommended to track progress.\n \nSide Effects:\n \n\nWhile GLIEMPAFLOZIN MET is generally well-tolerated, some individuals may experience:\n\nCommon Side Effects:\n\nNausea, vomiting, or diarrhea\nIncreased urination\nMild dehydration\nWeakness or dizziness\nSerious Side Effects (Seek Medical Attention):\n\nKetoacidosis: Unusual fatigue, nausea, vomiting, or breathing difficulties.\nUrinary Tract Infections (UTIs): Burning sensation while urinating, fever, or pelvic pain.\nLactic Acidosis (Rare but Severe): Muscle pain, trouble breathing, irregular heartbeat.\nIf any severe reactions occur, consult a doctor immediately.", "price": 115.0, "discountamount": 35.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "lower risk", "healthy diet", "commonly prescribed", "doctor immediately", "urinating fever", "generally welltolerated", "gliempaflozin met", "exercise routine", "chew maintain", "wellbeing directions", "body tissues", "diabetes medications", "hypoglycemia unlike", "heart disease", "weight loss", "bodys ability", "diabetesrelated complications", "empagliflozin 5mg", "effective management", "glucose utilization", "decreasing glucose production", "powerful antidiabetic agents" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2043, "imageuri": "https://productimages.withfloats.com/actual/67a35783a4575f9364b319c7.png", "tileimageuri": "https://productimages.withfloats.com/tile/67a35783a4575f9364b319c7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-05T12:19:51.149Z", "updatedon": "2025-03-22T10:21:42.769Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-5mg-metformin-hydrochloride-500mg-/2043", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN MET 5MG/ 500MG ", "category": "DIABETIC RANGE", "tags": [ "empagliflozin/metformin 5 mg/1000 mg", "empagliflozin + metformin combination brand name", "Empagliflozin and metformin hydrochloride tablets", "empagliflozin + metformin brand name in india", "empagliflozin 12.5 mg+metformin 500 mg price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66d83ad4ed345980e0fca5c5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Voglibose (0.3mg), Metformin (500mg), Gliclazide (80mg)", "description": "GLICLAGLAZE TRIO 0.3 \nVoglibose (0.3mg), Metformin (500mg), Gliclazide (80mg)\nGLICLAGLAZE TRIO 0.3 is a powerful combination medication designed to manage and control type 2 diabetes. It is formulated with three active ingredients: Voglibose, Metformin, and Gliclazide. This unique combination helps to regulate blood sugar levels effectively, providing a comprehensive approach to diabetes management. GLICLAGLAZE TRIO 0.3 is particularly useful for patients who require a multifaceted treatment strategy to keep their blood glucose levels in check.\n\n \n\nKey Benefits:\n \n\nEffective Blood Sugar Control: The combination of Voglibose, Metformin, and Gliclazide offers a synergistic effect, providing comprehensive control over blood sugar levels.\nPrevents Post-Meal Sugar Spikes: Voglibose helps in delaying glucose absorption, reducing the risk of hyperglycemia after meals.\nImproved Insulin Sensitivity: Metformin enhances the body's response to insulin, ensuring better glucose management.\nEnhanced Insulin Secretion: Gliclazide helps in stimulating insulin release from the pancreas, making it easier to maintain stable blood sugar levels.\n \n\nHow Does It Work?\n \n\nGLICLAGLAZE TRIO 0.3 works through a multi-pronged approach to manage diabetes. Voglibose slows down the absorption of carbohydrates in the gut, which helps to prevent rapid increases in blood sugar levels after meals. Metformin reduces the liver's glucose production and improves insulin sensitivity, ensuring better glucose uptake and utilization. Gliclazide stimulates the pancreas to release insulin, aiding in the reduction of blood glucose levels.\n\n \n\nDirections for Use:\n \n\nTake GLICLAGLAZE TRIO 0.3 as prescribed by your healthcare provider. It is typically taken before meals to maximize its effectiveness in controlling postprandial blood sugar spikes. Swallow the tablet whole with a glass of water. Do not crush or chew the tablet. Your doctor will determine the appropriate dosage and frequency based on your individual health needs.\n\n \n\nSide Effects:\n \n\nLike all medications, GLICLAGLAZE TRIO 0.3 may cause some side effects. Common side effects include gastrointestinal disturbances such as nausea, diarrhea, and abdominal pain. Hypoglycemia (low blood sugar) may occur, especially if you skip meals or engage in intense physical activity. Other possible side effects include dizziness, headache, and fatigue. If you experience any severe side effects or allergic reactions, seek medical attention immediately.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 185.0, "discountamount": 56.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Key Benefits", "abdominal pain", "glucose uptake", "type 2 diabetes", "rapid increases", "insulin release", "low blood sugar", "GLICLAGLAZE TRIO", "medical attention", "glucose absorption", "allergic reactions", "appropriate dosage", "synergistic effect", "unique combination", "glucose production", "glucose management", "diabetes management", "healthcare provider", "severe side effects", "Common side effects", "blood glucose levels", "comprehensive control", "multi-pronged approach", "comprehensive approach", "Post-Meal Sugar Spikes", "individual health needs", "three active ingredients", "intense physical activity", "stable blood sugar levels", "Enhanced Insulin Secretion", "Other possible side effects", "Improved Insulin Sensitivity", "gastrointestinal disturbances", "Effective Blood Sugar Control", "powerful combination medication", "multifaceted treatment strategy", "postprandial blood sugar spikes" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1962, "imageuri": "https://productimages.withfloats.com/actual/66d83afac7293b3595ec4ea6.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/66d83afac7293b3595ec4ea6.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-04T10:47:48.369Z", "updatedon": "2024-09-04T10:47:48.369Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/voglibose-0-3mg-metformin-500mg-gliclazide-80mg-/1962", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLICLAGLAZE TRIO 0.3 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }